ID   CGM1
AC   CVCL_7251
DR   CLO; CLO_0050078
DR   BioSample; SAMN03472291
DR   dbMHC; 48720
DR   ECACC; 94050319
DR   IHW; IHW09207
DR   IPD-IMGT/HLA; 10407
DR   RCB; RCB0566
DR   Wikidata; Q54811582
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*03:01:01:01,29:02; B*08:01:01,14:02:01; C*08:02,07:01:01; DPB1*04:01 (IPD-IMGT/HLA=10407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): RCB=RCB0566
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 8,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//